Emerging mycotoxins: Beyond traditionally determined food contaminants
C Gruber-Dorninger, B Novak, V Nagl… - Journal of agricultural …, 2017 - ACS Publications
Modern analytical techniques can determine a multitude of fungal metabolites contaminating
food and feed. In addition to known mycotoxins, for which maximum levels in food are …
food and feed. In addition to known mycotoxins, for which maximum levels in food are …
Alteration of the gut microbiome in mycophenolate-induced enteropathy: impacts on the profile of short-chain fatty acids in a mouse model
M Jardou, Q Provost, C Brossier, É Pinault… - BMC Pharmacology and …, 2021 - Springer
Background Mycophenolic acid (MPA) is the most widely used immunosuppressive drug in
transplantation and for autoimmune diseases. Unfortunately, more than 30% of patients …
transplantation and for autoimmune diseases. Unfortunately, more than 30% of patients …
An expert opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation and the Polish Society for Rheumatology on the diagnosis and treatment of …
T Mularek-Kubzdela, M Ciurzyński… - Polish Heart …, 2021 - journals.viamedica.pl
Systemic connective tissue diseases (CTDs) comprise a large group of diseases that are
auto-immune in nature and characterized by the involvement of multiple systems and …
auto-immune in nature and characterized by the involvement of multiple systems and …
[HTML][HTML] Gut microbiota biotransformation of drug glucuronides leading to gastrointestinal toxicity: Therapeutic potential of bacterial β-glucuronidase inhibition in …
C Brossier, M Jardou, A Janaszkiewicz, D Firoud, I Petit… - Life Sciences, 2024 - Elsevier
Aims Drug-induced enteropathy is often associated with the therapeutic use of certain
glucuronidated drugs. One such drug is mycophenolic acid (MPA), a well-established …
glucuronidated drugs. One such drug is mycophenolic acid (MPA), a well-established …
[HTML][HTML] Polysaccharide mycophenolate-based nanoparticles for enhanced immunosuppression and treatment of immune-mediated inflammatory diseases
Y Li, Y Lou, Y Chen, J Yang, D Li, B Jiang, J Lan… - Theranostics, 2021 - ncbi.nlm.nih.gov
Immune-mediated inflammatory diseases (IMIDs) are characterized by immune
dysregulation and severe inflammation caused by the aberrant and overactive host …
dysregulation and severe inflammation caused by the aberrant and overactive host …
Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a phase …
B Manger, F Hiepe, M Schneider, M Worm… - Clinical and …, 2015 - Taylor & Francis
Background The purpose of this study was to assess changes in gastrointestinal symptom
severity in patients with autoimmune disease who were switched from mycophenolate …
severity in patients with autoimmune disease who were switched from mycophenolate …
Immunotherapeutics in pediatric autoimmune central nervous system disease: agents and mechanisms
Beyond the major advances produced by careful clinical-radiological phenotyping and
biomarker development in autoimmune central nervous system disorders, a comprehensive …
biomarker development in autoimmune central nervous system disorders, a comprehensive …
Opinia ekspertów Sekcji Krążenia Płucnego Polskiego Towarzystwa Kardiologicznego oraz Polskiego Towarzystwa Reumatologicznego dotycząca diagnostyki i …
T Mularek-Kubzdela, M Ciurzyński… - Rheumatology …, 2021 - journals.viamedica.pl
Układowe choroby tkanki łącznej (CTD, connective tissue diseases) obejmują dużą grupę
chorób, które cechują się zajęciem wielu układów i narządów, i mają charakter …
chorób, które cechują się zajęciem wielu układów i narządów, i mają charakter …
[PDF][PDF] 3.1 Immune therapy agents and their mechanisms of action
Beyond the major advances produced by careful clinical-radiological phenotyping and
biomarker development in autoimmune central nervous system disorders, a comprehensive …
biomarker development in autoimmune central nervous system disorders, a comprehensive …
[PDF][PDF] Emerging mycotoxins: Beyond traditionally determined food contaminants
Emerging mycotoxins: Beyond traditionally determined food contaminants Page 1 This
document is confidential and is proprietary to the American Chemical Society and its authors …
document is confidential and is proprietary to the American Chemical Society and its authors …